Data Sheet 1_Association between steatotic liver disease subtype and thyroid cancer in wom

A nationwide population-based cohort study of 2,089,609 women in South Korea aged over 40, who participated in a 2009 health screening and were followed until 2022. The research, authored by Hyunju Park, investigates the association between subtypes of steatotic liver disease and the risk of thyroid cancer. During a mean follow-up of 12.27 years, 40,072 (1.92%) women were newly diagnosed with thyroid cancer.

Use Cases

• Assessing thyroid cancer risk based on steatotic liver disease subtype classification (MASLD, MetALD, ALD).
• Analyzing hazard ratios for thyroid cancer across different menopausal statuses (premenopausal vs. postmenopausal).
• Investigating population-level associations between metabolic dysfunction-associated steatotic liver disease (MASLD) and cancer incidence.

Strengths

• Large cohort size of 2,089,609 women provides statistical power.
• Longitudinal design with a mean follow-up period of 12.27 years.
• Clear hazard ratio results reported with 95% confidence intervals.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data is contained in a DOCX file (323.7 KB), suggesting the primary data may be summarized results rather than raw patient-level records.

Provenance

Source

Hyunju Park via figshare.

Collection Method

Nationwide population-based cohort study using health screening program data.

Time Range

Cohort enrolled in 2009, followed until 2022.

Freshness

Last updated 2026-05-21 04:36:56; freshness should be verified.

Geography

Nationwide study in South Korea (inferred from context).